Heron Therapeutics(US:HRTX) Globenewswire·2025-10-21 20:20Core Viewpoint - Heron Therapeutics, Inc. will host a conference call on November 4, 2025, to report its third quarter 2025 financial results and discuss recent business highlights [1]. Group 1: Conference Call Details - The conference call will take place at 8:30 a.m. ET and can be accessed via a registration link for dial-in details [2]. - Participants are encouraged to join the call fifteen minutes early to avoid delays [2]. - The call will also be available as a webcast on Heron's website, with an archive accessible for 60 days post-call [2]. Group 2: Company Overview - Heron Therapeutics is a commercial-stage biotechnology company focused on developing therapeutic innovations to improve patient care [3]. - The company utilizes advanced science, patented technologies, and an innovative approach to drug discovery and development [3]. - Heron aims to advance the standard-of-care for acute care and oncology patients through its portfolio of products [3].